Welcome to our dedicated page for CIBUS SEC filings (Ticker: CBUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cibus, Inc. (Nasdaq: CBUS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information on Cibus’ operations as an agricultural technology company that develops and licenses gene-edited plant traits to seed companies.
Through its recent Forms 8-K, Cibus has reported a range of material events, such as quarterly financial results and business updates, workforce reduction decisions, and the appointment of key executives and directors. For example, filings describe the appointment of a Chief Financial Officer under an executive employment agreement, the election of new board members with experience in technology, agriculture and finance, and actions to streamline the business by consolidating facilities and reducing headcount.
These filings also confirm that Cibus’ Class A common stock, with par value $0.0001 per share, is registered under Section 12(b) of the Exchange Act and trades on The Nasdaq Stock Market LLC under the symbol CBUS. Investors reviewing the filings can see how the company describes its focus on productivity traits for major row crops, its reliance on licensing and royalty arrangements, and its assessment of risks and strategic alternatives as referenced in its periodic reports.
On Stock Titan, Cibus filings are supplemented with AI-powered summaries that help explain the key points of lengthy documents, such as current reports on Form 8-K or sections of annual and quarterly reports. Users can quickly identify items related to executive changes, cost structure adjustments, or updates to trait development programs, and then drill down into the full text for more detail. Real-time updates from EDGAR, combined with AI-generated highlights, make it easier to track CBUS regulatory disclosures, including insider-related items reported on Form 4 and the narrative and risk discussions contained in Forms 10-K and 10-Q.
Cibus, Inc. senior vice president of research Noel Sauer reported a routine tax-withholding disposition of 1,763 shares of Class A Common Stock on March 30, 2026. The shares were valued at a weighted average price of $1.84 per share. After this transaction, Sauer directly owns 101,879 shares of Cibus stock.
Cibus, Inc. chief legal officer Jason Stokes reported a routine tax-related share disposition. On March 30, 2026, 3,695 shares of Class A Common Stock were withheld at a weighted average price of $1.83 per share to cover tax obligations. The withheld shares came from multiple trades priced between $1.81 and $1.88. After this transaction, Stokes directly held 110,865 shares of Cibus common stock.
Cibus, Inc. CFO Broos Carlo reported a tax-related share disposition. On this Form 4, 3,676 shares of Class A Common Stock were disposed of at a weighted average price of $1.87 per share to satisfy tax obligations by delivering securities. After this transaction, Carlo directly holds 97,275 shares.
This was a tax-withholding disposition tied to equity compensation rather than an open-market trade, so it functions as an administrative event and does not reflect an active buy or sell decision on the open market.
Cibus, Inc. Chief Scientific Officer and EVP Gregory Francis William Gocal reported a routine tax-withholding disposition of 8,954 shares of Class A Common Stock. The shares were applied at a weighted average price of $1.82 per share. After this transaction, he directly holds 365,890 shares of Cibus common stock.
Cibus, Inc. director and interim CEO, president and COO Peter Beetham reported a tax-withholding disposition of 16,112 shares of Class A Common Stock on March 30, 2026. The weighted average price was $1.85 per share, with trades ranging from $1.81 to $2.10. Following this withholding to cover obligations, he directly holds 491,825 shares, indicating this was a routine compensation-related event rather than an open-market sale.
Cibus, Inc. entered an underwriting agreement with BTIG, LLC for an underwritten public offering of 6,976,744 shares of Class A common stock at $2.15 per share. The company expects net proceeds of about $13.5 million, or $16.0 million if the 1,046,511-share overallotment option is fully exercised.
The offering is expected to close on or about March 27, 2026, subject to customary conditions, under a previously effective Form S-3 shelf registration. The underwriter will receive a 7.0% discount on gross proceeds, and directors, officers and the company agreed to a 60-day lock-up on additional sales, with customary exceptions.
Cibus, Inc. is offering 6,976,744 shares of Class A Common Stock at $2.15 per share. The offering includes a 30-day underwriter option to purchase up to an additional 1,046,511 shares and is expected to deliver on or about March 27, 2026. Net proceeds are estimated at approximately $13.5 million (or approximately $16.0 million if the option is exercised in full).
The company intends to use proceeds for working capital and to fund further development of its Rice weed management traits. Financial context disclosed: as of December 31, 2025, Cibus reported $9.9 million in cash and cash equivalents and $16.9 million in current liabilities, and the audit report contains a going concern explanatory paragraph.
Cibus, Inc. is offering shares of its Class A Common Stock and pre-funded warrants pursuant to a preliminary prospectus supplement dated March 25, 2026. The offering is being sold on a firm commitment underwritten basis with a 30-day option for additional shares.
The filing discloses $9.9 million of cash and cash equivalents and $16.9 million of current liabilities as of December 31, 2025, and states there is substantial doubt about Cibus’ ability to continue as a going concern without additional financing. The company intends to use net proceeds for working capital and continued development of its Rice herbicide tolerance traits.
Cibus, Inc. CFO Carlo Broos reported a small share disposition related to tax withholding. On this Form 4, 1,496 shares of Class A Common Stock were surrendered at $1.32 per share to cover tax obligations rather than sold on the open market. After this transaction, he directly holds 100,951 shares, so his overall ownership stake remains largely unchanged.
Cibus, Inc. senior vice president of research Noel Sauer reported two transactions in Class A common stock. On November 11, 2025, 1,834 shares were disposed of at $1.32 per share as a tax-withholding transaction, rather than an open-market trade. Earlier, on June 13, 2025, Sauer completed a small open-market sale of 4 shares at $1.485 per share. Following these transactions, Sauer directly holds 103,642 shares of Cibus Class A common stock.